Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Pozycja w akcjach #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Cena akcji
$29.82
Ostatnia synchronizacja: 2023-04-11
Kapitalizacja rynkowa
$223.68M
Zmiana (1 dzień)
1.21%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel Neovasc Inc. (NVCN)

Kategoria

Historia ceny akcji dla Neovasc Inc. (NVCN)
Najwyższa cena zamknięcia: $29.60 dnia 2023-04-01

Najniższa cena zamknięcia: $112.36K dnia 2001-05-01
Historia cen akcji firmy Neovasc Inc. od 2001 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 172.80%
2022 -25.78%
2021 -31.79%
2020 -74.55%
2019 -50.59%
2018 -98.94%
2017 -64.07%
2016 -55.36%
2015 -36.86%
2014 67.21%
2013 128.15%
2012 15.35%
2011 43.26%
2010 185.91%
2009 230.48%
2008 -93.29%
2007 -55.72%
2006 -51.21%
2005 -33.47%
2004 -27.51%
2003 49.66%
2002 62.92%
2001 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$110.59 -16.34%
US
$312.39 -19.60%
US
$92.11 -0.15%
IE
$48.42 -54.97%
US
$90.87 11.88%
US